Academic Journal

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study

التفاصيل البيبلوغرافية
العنوان: Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
المؤلفون: Pan, Jing, Tang, Kaiting, Luo, Yuechen, Seery, Samuel, Tan, Yue, Deng, Biping, Liu, Feng, Xu, Xiuwen, Ling, Zhuojun, Song, Weiliang, Xu, Jinlong, Duan, Jiajia, Wang, Zelin, Li, Chunyu, Wang, Kai, Zhang, Yibing, Yu, Xinjian, Zheng, Qinlong, Zhao, Liping, Zhang, Jiecheng, Chang, Alex H, Feng, Xiaoming
المصدر: The Lancet Oncology ; volume 24, issue 11, page 1229-1241 ; ISSN 1470-2045
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s1470-2045(23)00436-9
الاتاحة: https://doi.org/10.1016/s1470-2045(23)00436-9
https://api.elsevier.com/content/article/PII:S1470204523004369?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1470204523004369?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; https://doi.org/10.15223/policy-017 ; https://doi.org/10.15223/policy-037 ; https://doi.org/10.15223/policy-012 ; https://doi.org/10.15223/policy-029 ; https://doi.org/10.15223/policy-004
رقم الانضمام: edsbas.E424271F
قاعدة البيانات: BASE
الوصف
DOI:10.1016/s1470-2045(23)00436-9